Lipoprotein triglyceride and cholesterol concentrations and characteristics are described in normolipidemic and in three categories of hyperlipidemic subjects participating in the Pacific Northwest Bell Telephone Company Health Survey. For this study, 350 white participants 20 to 59 years of age with cholesterol or triglyceride values exceeding the age, sex, and hormone-use specific, population-based 90th percentile values were defined as having hypercholesterolemia, hypertriglyceridemia, or combined hyperlipidemia; 722 participants were classified as normolipidemic. In hypercholesterolemia, very low density lipoprotein cholesterol and triglyceride and high density lipoprotein cholesterol concentrations were higher than in normolipidemia. In hypertriglyceridemia, high density lipoprotein cholesterol was significantly lower in men and women not using sex hormones and low density lipoprotein triglyceride was significantly higher in men and women using hormones compared to normolipidemia. In combined hyperlipidemia, high density lipoprotein cholesterol concentrations were lower than in normolipidemia, but higher than in pure hypertriglyceridemia. The presence of beta migrating very low density lipoprotein and chylomicrons was seen primarily in hypertriglyceridemic or combined hyperlipidemic men. Sinking prebeta lipoprotein was equally common (20%) among all normolipidemic and hypercholesterolemic subjects, but was less common (5% to 10%) in hypertriglyceridemic and combined hyperlipidemic men and female hormone users. Quantitative and qualitative lipoprotein abnormalities associated with hyperlipidemia were found to vary by gender and by sex hormone use in women and were often, but not always, more marked in men. (Arteriosclerosis 3:117-124, March/April 1983)
R esults from the Lipid Research Clinics (LRC)
Program collaborative population studies 1 and the Northwest Lipid Research Clinic survey of Pacific Northwest Bell Telephone Company employees have established percentile levels of cholesterol and triglyceride that are useful in identifying elevated concentrations. 2 3 There are few studies describing lipoprotein triglyceride and cholesterol concentra-tions or qualitative lipoprotein abnormalities associated with empirically defined hyperlipidemia as compared to normolipidemia.
Alterations in lipoprotein triglyceride as well as cholesterol have potential pathophysiological importance. An elevation of both triglyceride and cholesterol (termed combined hyperlipidemia in this paper) is more commonly observed in survivors of myocardial infarction than are elevations of either triglyceride or cholesterol alone. 4 "* Triglyceride content of very low, low, and high density lipoproteins (VLDL, LDL, and HDL, respectively) is increased among myocardial infarction survivors. 8 The objective of this paper is to describe lipoprotein cholesterol and triglyceride concentrations and qualitative abnormalities in subjects classified as hyperlipidemic or normolipidemic for clinical rather than epidemiological purposes. In this analysis, a hyperli-pidemic subject was arbitrarily defined as having either plasma cholesterol or triglyceride concentrations, or both, that exceeded the age, sex, and hormone-use specific 90th percentile values estimated from a local population study. 2 ' 3 Plasma cholesterol and triglyceride measurements were used for classification instead of lipoprotein lipids because plasma lipids are most often known in both clinical and research settings; due to larger sample sizes our local 90th percentile values are more accurately estimated and thus more representative of the population screened. The classification resulted in three categories of hyperlipidemia: hypercholesterolemia, hypertriglyceridemia, and combined hyperlipidemia.
The data were used to address several questions: 1) How do concentrations of lipoprotein cholesterol and triglyceride differ from normolipidemia in individuals classified as having hypercholesterolemia, hypertriglyceridemia, or combined hyperlipidemia? 2) Are lipoprotein differences associated with these hyperlipidemias similar among men, women using sex steroid hormones, and women not using hormones, or are they more exaggerated among men whose risk of atherosclerosis is higher?
Methods
Eleven North American clinics participated in the population studies of the LRC Program under a common protocol. 9 The study population of the Northwest Lipid Research Clinic (NWLRC) consisted of Pacific Northwest Bell Telephone Company employees in King County, Washington. An initial screening of the 5000 eligible employees (Visit 1) provided information on fasting plasma lipid levels relative to age, sex, race, and gonadal hormone use. 2 At a second visit (Visit 2) a subset (n = 1190) of the Visit 1 participants had determinations of cholesterol and triglycerides in whole plasma and of VLDL, LDL, and HDL fractions. This subset consisted of a 15% random sample of Visit 1 participants and all subjects with cholesterol and triglyceride levels above nationally determined cutpoints. 10 Triglyceride and cholesterol in plasma and the lipoprotein fractions were measured using methods previously described for the Lipid Research Clinics Program. 10 VLDL lipids were calculated as the difference between their concentrations in the plasma and in the d = 1.006 infranatant solution obtained by ultracentrifugation at 40,000 RPM (105,000 x g) for 18 hours at 10°C. HDL lipids were measured in the heparin-manganese chloride supernates after VLDL and LDL precipitation. 10 LDL lipids were calculated as the difference between their concentrations in the d = 1.006 infranate and the heparin-manganese supemate. Analytical performance and quality control procedures associated with the measurements of triglyceride and cholesterol in the lipoprotein fractions are described by Wahl et al. 3 Beta VLDL or floating beta lipoprotein was detected as a band with beta or near-beta mobility on agarose electrophoresis of the d < 1.006 lipoprotein fraction after ultracentrifugation at d = 1.006. 10 The sinking prebeta lipoprotein was detected as a band with prebeta mobility on agarose electrophoresis of the d > 1.006 fraction. 10 The presence of chylomicrons was determined by visual inspection of plasma after overnight storage at 4°C. 10 This analysis was restricted to whites 20 13 were used to determine the significance of differences among groups.
Results

Age and Relative Weight
Ages were similar in normolipidemic, hypercholesterolemic, and hypertriglyceridemic subjects within the male, female nonuser, and female user groups ( Table 1 ). The mean ages of combined hyperlipidemics were different from subjects in the other lipid classes, males and female users being 3 to 5 years younger and female nonusers, 2 years older. None of these differences was statistically significant. Relative weight, estimated by Quetelet's Index, was statistically indistinguishable between normolipidemic and hypercholesterolemic subjects. Hypertriglyceridemic and combined hyperlipidemic subjects had higher Quetelet's Index values.
Lipoprotein Cholesterol Concentrations
Total and lipoprotein cholesterol concentrations in normolipidemic and hyperlipidemic subjects are presented in Table 2 . By definition, total plasma cholesterol concentrations were significantly higher in the hypercholesterolemic and combined hyperlipidemic groups. Total plasma cholesterol concentrations in hypertriglyceridemic subjects were generally slightly higher than in the normolipidemic subjects. In the VLDL fraction, cholesterol concentrations were significantly higher in hypertriglyceridemic and combined hyperiipidemic subjects compared to normolipidemics and hypercholesterolemics. In hypercholesterolemic subjects, VLDL cholesterol levels were higher than in normolipidemics, significantly so in males, but were lower than in the hypertriglyceridemic or combined hyperiipidemic groups. Differences in LDL cholesterol concentrations reflected those seen in total cholesterol and, as expected, were the largest in hypercholesterolemic and combined hyperiipidemic subjects. HDL cholesterol was significantly lower in hypertriglyceridemic and combined hyperiipidemic male subjects compared to both normolipidemics and hypercholesterolemics. In female nonusers, HDL cholesterol was significantly lower in hypertriglyceridemics but not in combined hyperlipidemics. However, for both men and nonusers, HDL cholesterol was lower in hypertriglyceridemics than in combined hyperlipidemics. In female hormone users, reductions in HDL cholesterol were small and not significant in these two hyperiipidemic groups. An interesting trend in all hypercholesterolemic groups was a consistent, but nonsignificant, elevation in HDL cholesterol concentration of 3 to 7 mg/ dl compared to normolipidemics.
Comparisons among the classes of hyperlipidemia and among men, nonusers, and users are made in Figure 1 A where the differences in lipoprotein cholesterol concentrations above or below the normolipidemic baseline are illustrated. In hypercholesterolemia, the increments above baseline in VLDL cholesterol were small overall, but greatest in men. The amount of LDL cholesterol above baseline was large but equivalent for the three gender and hormone-use groups. In hypertriglyceridemia, men exhibited the greatest positive difference in VLDL cholesterol and the greatest negative difference in LDL cholesterol. Only women nonusers had an LDL cholesterol above normolipidemia. In HDL, the greatest cholesterol decrement was in female nonusers. In combined hyperiipidemia, the greatest cholesterol elevation in VLDL was again in men. In LDL, the greatest cholesterol increment was in women nonusers. In HDL, reductions were small but greatest in men.
Lipoprotein Triglyceride Concentrations
Total and lipoprotein triglyceride concentrations in normolipidemic and hyperiipidemic subjects are presented in Table 3 . By definition, total plasma triglyceride concentrations were significantly higher in the hypertriglyceridemic and combined hyperiipidemic groups. In addition, total plasma triglyceride concentrations were significantly higher in hypercholesterolemic males. In females, small triglyceride elevations were noted in hypercholesterolemia compared to normolipidemia.
In VLDL, triglyceride concentrations were significantly higher in the hypertriglyceridemic and combined hyperiipidemic groups reflecting the higher total plasma triglyceride levels. In the hypercholesterolemic subjects, VLDL triglyceride was slightly higher than in normolipidemics. In LDL, plasma triglyceride values were higher by comparable amounts in hypercholesterolemic and hypertriglyceridemic subjects. The highest LDL triglyceride concentrations were observed in combined hyperiipidemic subjects. HDL triglyceride levels were similar in normolipidemic and hypercholesterolemic subjects, but were significantly higher in hypertriglyceridemic and combined hyperiipidemic males and female hormone users. In females not taking hormones, significantly higher HDL triglyceride concentrations were associated only with combined hyperlipidemia. The largest values of HDL triglyceride were observed in the hypertriglyceridemic and combined hyperiipidemic hormone users.
Comparisons among the categories of hyperlipidemia and among men, nonusers, and users are made in Figure 1 B where the increments in lipoprotein triglyceride concentrations from the normolipide- mic baseline are illustrated. In hypercholesterolemia, VLDL and HDL triglyceride concentrations were slightly above baseline with no consistent association with gender or hormone use. On the other hand, in hypertriglyceridemia and combined hyperlipidemia, the amount of VLDL triglyceride above baseline was 50% to 100% greater in men than in women users or nonusers. LDL triglyceride elevations in hypertriglyceridemia and combined hyperlipidemia showed no sex hormone or gender association, in contrast to HDL, where the amount of triglyceride above baseline was greatest with hormone use.
LIpoproteIn Variants
Lipoprotein variant forms including the presence of chylomicrons, beta VLDL and sinking prebeta bands are presented in Table 4 . The presence of chylomicrons and beta VLDL was primarily confined to male subjects. Chylomicronemia was observed in 1.3% of the normolipidemic males, but was eight times more common in hypertriglyceridemic male subjects. In contrast, chylomicronemia in combined hyperiipidemic males was only one-fourth as common as in hypertriglyceridemia, even though total plasma triglyceride concentrations were similar in the two groups (see Table 3 ). The total plasma tri- concentrations, 32.3 ± 5.1 mg/dl, similar to levels characteristic of hypertriglyceridemic men ( Table 2) . The one woman with a beta VLDL band was normolipidemic and did not take sex hormones. Her VLDL cholesterol level was 23 mg/dl which is high relative to her triglyceride concentration of 10 mg/dl. Her HDL cholesterol level of 59 mg/dl was slightly above the average for normolipidemic nonusers.
The prevalence of sinking prebeta lipoprotein was approximately 20% in both normolipidemic and hypercholesterolemic groups. Women with hypertriglyceridemia not taking hormones exhibited a comparable rate, 21.5%. However, in males and in female hormone users, hypertriglyceridemia was associated with a lower percentage of sinking prebeta lipoprotein, 5.3% and 7.1%, respectively. In combined hyperlipidemia the occurrence was 10% for males and hormone users and 16.7% for nonusers.
glyceride concentration in the eight hypertriglyceridemic, chylomicronemic men was 512 ± 225 mg/dl (mean ± SD) and was 524 mg/dl in the combined hyperlipidemic man.
The proportion of individuals with beta VLDL was low in the normolipidemic group (0.5%). Beta VLDL was not detected in any hypercholesterolemic subjects, but was found five times more often in hypertriglyceridemia and 10 times more often in combined hyperiipidemia than in normolipidemia. Male subjects with beta VLDL (n = 6) differed from other men in that they had generally high VLDL cholesterol concentrations, 90.7 ± 42.5 mg/dl, low HDL cholesterol 
Discussion
In this paper we describe total plasma and lipoprotein cholesterol and triglyceride concentrations associated with hypercholesterolemia, hypertriglyceridemia, and combined hyperlipidemia. The three hyperlipidemic groups are defined in terms of cholesterol or triglyceride levels that exceed age, sex, and sex hormone-use specific 90th percentile values. These classifications dictate the elevation of VLDL triglyceride and cholesterol in hypertriglyceridemia and an elevation of LDL triglyceride and cholesterol in hypercholesterolemia. Lipoprotein lipid concentrations not fixed by the definition of each hyperiipidemia category are also of interest in this paper.
In hypercholesterolemic subjects, concentrations above those of normolipidemia are seen in VLDL triglyceride and cholesterol, LDL triglyceride, and HDL cholesterol. Triglyceride concentrations in VLDL are 13% and 24% higher in hypercholesterolemic males and female nonusers, respectively, than in normolipidemics. Previously, twofold elevations were observed in the familial and polygenic hypercholesterolemic survivors of myocardial infarction studied by Hazzard et al. 14 The higher VLDL levels associated with hypercholesterolemia may reflect a defect in VLDL catabolism that is related to the pathophysiology of the higher LDL concentrations or to an overproduction of VLDL with more LDL as a byproduct. 15 LDL triglyceride is 26% to 47% higher in hypercholesterolemia. Such an increase has been reported by Carlson et al. 8 in myocardial infarction survivors. An interesting observation in the present study is the consistently high HDL cholesterol concentrations associated with hypercholesterolemia, especially in women. A similar trend was observed in the primarily male polygenic hypercholesterolemic survivors of myocardial infarction studied by Hazzard et al. 14 In hypertriglyceridemic subjects, triglyceride concentrations are higher not only in VLDL, but also in Predictions of the significance for atherosclerosis risk are difficult to make on this basis alone since studies in animal models show an increase in LDL triglyceride relative to cholesterol to be associated with protection from atherosclerosis. 1617 While this relationship is yet to be tested in humans, it is possible that atherosclerosis risk in hypertriglyceridemic subjects is related to abnormalities in other lipoprotein fractions, such as a reduction in HDL cholesterol.
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Lipoprotein triglyceride content in hypertriglyceridemia varies with sex hormone treatment, but not by gender. For instance, the higher LDL triglyceride concentration seen in sex hormone users reflects the higher baseline LDL triglyceride concentration in women hormone users from a general population as described previously. 3 The difference between HDL triglyceride concentrations in hypertriglyceridemic hormone users and in normolipidemic users is much greater than in either hypertriglyceridemic men or women nonusers, even when baseline differences are considered. A sex hormone-related difference is also observed in HDL cholesterol which is substantially lower in hypertriglyceridemic males and women not using hormones than in women using hormones. In summary, differences in HDL triglyceride and cholesterol are similar in men and in nonusers with hypertriglyceridemia. The lack of a significantly lower HDL cholesterol in hypertriglyceridemic hormone users might indicate a different pathophysiology such as an increased rate of HDL formation linked to enhanced triglyceride entry and removal as seen in estrogen treatment 20 and pregnancy. 21 It should be noted that the hormone user group consists of oral contraceptive and postmenopausal estrogen users. As has been previously shown, 22 ' a the chemical formulations of these types of hormones have differing effects on lipoprotein lipid concentrations. However, due to our small sample sizes, the effects of these differences could not be analyzed separately.
Combined hyperiipidemia is of particular interest since it is associated with a higher risk for atherosclerosis than that seen with hypertriglyceridemia or hypercholesterolemia alone, as reported in numerous studies of myocardial infarction survivors. 4 " 8 - 24 In the present study, combined hyperlipidemia is associated on the average with high concentrations of both cholesterol and triglyceride in VLDL and LDL and low HDL cholesterol. Looking at individual subjects with combined elevations of triglyceride and cholesterol, an elevation in VLDL cholesterol often contributes to the increase in total cholesterol, particularly in males, but LDL cholesterol is always elevated above the 75th percentile and is above the 90th percentile in the majority of subjects. The elevated VLDL and LDL levels apparently indicate an abnormality in the rate of VLDL secretion, conversion of VLDL to LDL, or LDL catabolism, as explained by Lewis. 25 Some comment on the differences between male and female combined hyperiipidemics is justified since previous studies of familial combined hyperlipidemia have been largely confined to men. In combined hyperlipidemia, HDL cholesterol concentrations are not as low in women not using hormones as they are in men, and women using hormones have similar concentrations as hypertriglyceridemic women who take sex hormones. Furthermore, combined hyperiipidemic hormone users are different from men and nonusers in that their median VLDL triglyceride level is higher than that of hypertriglyceridemics, and the known inverse relationship between total triglyceride and HDL cholesterol is not observed.
Gender and sex-hormone use differences are also apparent in the manifestations of qualitative lipoprotein abnormalities associated with hyperlipidemia. Beta VLDL, a condition of Type III hyperlipidemia, and chylomicronemia are confined almost exclusively to men. These findings are consistent with the view that estrogen treatment and the female gender are more favorable conditions for the removal of betamigrating VLDL and chylomicron triglycerides. These effects have also been observed in pregnancy, 21 in estrogen treatment, 20 and in estrogen-treated Type III hyperiipidemic subjects. 2627 Systems for classifying hyperlipidemias are varied and, to some extent, controversial. The classical lipoprotein phenotypes of Fredrickson, et al. 28 are not necessarily diagnostic of genetically transmitted disorders, and clinicians generally do not have sufficient laboratory measurements to use the phenotyping system. Recently, attention has focused on the definition of hyperlipidemia on the basis of populationbased lipid concentrations adjusted for age, sex, and hormone use. Reference standards for lipoproteins have recently been published for the Lipid Research Clinics Program 1 as well as for a number of component population studies, including the Pacific Northwest Bell study in the Puget Sound area.
2 ' 3 The classifications of hyperlipidemia in this study are based on a single measurement; in clinical practice additional observations and other reference values could be used in diagnosis and treatment. However, our findings show that such a screening procedure will identify subjects with potential lipoprotein abnormalities. Obviously, this approach does not preclude interest in lipoprotein subclasses and apoproteins in the regulation of lipid transport. Nonetheless, Hulley and Rhoads 29 found total plasma cholesterol to be as good as LDL as an indicator of heart disease risk in most clinical situations. Our results indicate that screening for hyperlipidemia on the basis of total plasma triglyceride and cholesterol concentrations provides a practical approach to risk factor detection and heart disease prevention.
